| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Teriparatide | FAERS: 5 | US FAERS | |
| 2 | Pregabalin | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 3 | lifitegrast | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 4 | Amiodarone | FAERS: 3 | US FAERS | |
| 5 | Bimatoprost | FAERS: 3 | US FAERS | |
| 6 | Acyclovir | FAERS: 2 | US FAERS | |
| 7 | Amiodarone | FAERS: 2 | US FAERS | |
| 8 | Cefuroxime | FAERS: 2 | US FAERS | |
| 9 | Duloxetine Hydrochloride | FAERS: 2 | US FAERS | |
| 10 | Erlotinib Hydrochloride | FAERS: 2 | US FAERS | |
| 11 | Glatiramer Acetate | FAERS: 2 | US FAERS | |
| 12 | Latanoprost | FAERS: 2 | US FAERS | |
| 13 | Olanzapine | FAERS: 2 | US FAERS | |
| 14 | Tiotropium Bromide | FAERS: 2 | US FAERS | |
| 15 | Valsartan | FAERS: 2 | US FAERS | |
| 16 | Zoledronic Acid | FAERS: 2 | OFFSIDES US FAERS | |
| 17 | benazepril | FAERS: 2 | US FAERS | |
| 18 | dorzolamide | FAERS: 2 | US FAERS | |
| 19 | Amantadine | FAERS: 1 | US FAERS | |
| 20 | Atorvastatin | FAERS: 1 | US FAERS | |
| 21 | Bortezomib | FAERS: 1 | US FAERS | |
| 22 | Capecitabine | FAERS: 1 | US FAERS | |
| 23 | Carbamazepine | FAERS: 1 | US FAERS | |
| 24 | Celecoxib | FAERS: 1 | US FAERS | |
| 25 | Dasatinib | FAERS: 1 | US FAERS | |
| 26 | Ezetimibe, Simvastatin Drug Combination | FAERS: 1 | US FAERS | |
| 27 | Fingolimod Hydrochloride | FAERS: 1 | US FAERS | |
| 28 | Fluticasone | FAERS: 1 | US FAERS | |
| 29 | Gabapentin | FAERS: 1 | US FAERS | |
| 30 | Ganfort | FAERS: 1 | US FAERS | |
| 31 | Hydroxychloroquine | FAERS: 1 | US FAERS | |
| 32 | Isotretinoin | FAERS: 1 | US FAERS | |
| 33 | Letrozole | FAERS: 1 | OFFSIDES US FAERS | |
| 34 | Leuprolide | FAERS: 1 | US FAERS | |
| 35 | Liraglutide | FAERS: 1 | US FAERS | |
| 36 | Loteprednol Etabonate | FAERS: 1 | US FAERS | |
| 37 | Memantine | FAERS: 1 | US FAERS | |
| 38 | Methotrexate | FAERS: 1 | US FAERS | |
| 39 | Methylprednisolone Hemisuccinate | FAERS: 1 | US FAERS | |
| 40 | Minocycline | FAERS: 1 | US FAERS | |
| 41 | N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine | FAERS: 1 | US FAERS | |
| 42 | Oxcarbazepine | FAERS: 1 | US FAERS | |
| 43 | Pemetrexed | FAERS: 1 | US FAERS | |
| 44 | Raloxifene Hydrochloride | FAERS: 1 | US FAERS | |
| 45 | Restasis | FAERS: 1 | US FAERS | |
| 46 | Risperidone | FAERS: 1 | US FAERS | |
| 47 | Rosuvastatin Calcium | FAERS: 1 | US FAERS | |
| 48 | Timolol | FAERS: 1 | OFFSIDES US FAERS | |
| 49 | Topiramate | FAERS: 1 | US FAERS | |
| 50 | Travoprost | FAERS: 1 | US FAERS | |
| 51 | etonogestrel | FAERS: 1 | US FAERS | |
| 52 | rofecoxib | FAERS: 1 | US FAERS | |
| 53 | teduglutide | FAERS: 1 | US FAERS | |
| 54 | Alendronate | OFFSIDES | ||
| 55 | Anastrozole | OFFSIDES | ||
| 56 | Clindamycin | OFFSIDES | ||
| 57 | Dapsone | OFFSIDES | ||
| 58 | Desonide | OFFSIDES | ||
| 59 | Desoximetasone | OFFSIDES | ||
| 60 | Etodolac | OFFSIDES | ||
| 61 | Fluorouracil | OFFSIDES | ||
| 62 | Imipramine | OFFSIDES | ||
| 63 | Ketoprofen | OFFSIDES | ||
| 64 | Lenalidomide | OFFSIDES | ||
| 65 | Methylprednisolone Acetate | OFFSIDES | ||
| 66 | Mometasone Furoate | OFFSIDES | ||
| 67 | Nabumetone | OFFSIDES | ||
| 68 | Orphenadrine | OFFSIDES | ||
| 69 | Oxaprozin | OFFSIDES | ||
| 70 | Pamidronate | OFFSIDES | ||
| 71 | Penicillin V | OFFSIDES | ||
| 72 | Piroxicam | OFFSIDES | ||
| 73 | Pramipexole | OFFSIDES | ||
| 74 | Primidone | OFFSIDES | ||
| 75 | Quinidine | OFFSIDES | ||
| 76 | Tamoxifen | OFFSIDES | ||
| 77 | Triamcinolone | OFFSIDES | ||
| 78 | chlorhexidine gluconate | OFFSIDES | ||
| 79 | desloratadine | OFFSIDES | ||
| 80 | mannosamine | OFFSIDES | ||
| 81 | moexipril | OFFSIDES | ||
| 82 | nimesulide | OFFSIDES | ||
| 83 | pegaptanib | SIDER | ||
| 84 | valdecoxib | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.